Taichung Veterans General Hospital
Taichung, 40705, Taiwan
NCT Number: NCT05374980
Helicobacter pylori is a common pathogen causing upper gastrointestinal diseases including gastric ulcer and gastric cancer. Recent epidemiological findings have also shown that it is also related to colon cancer, metabolic syndrome, gut dysbiosis, glycemic control and insulin resistance.
The aim of this study is to investigate whether the gut microbiota and insulin resistance of patients with H. pylori infection are abnormal. In addition, whether drinking fermented milk product with probiotic reduces Helicobacter pylori, improves gut microbiota, and increases butyrate-producing bacteria and insulin resistance.
Looking for future studies?
Notify Me20 year–70 year
All sexes
Interventional
Not applicable
Taichung, 40705, Taiwan
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Drink a bottle of 200ml yogurt every morning and evening for 8 weeks
Drink a bottle of 200ml placebo every morning and evening for 8 weeks
Time frame: Baseline to day 28 and day 56
uses high-throughput sequencing to sequence the 16S rRNA
Time frame: Baseline to day 28 and day 56
Delta urea breath test
Time frame: Baseline to day 28 and day 56
weight in kilograms
Time frame: Baseline to day 28 and day 56
waist in centimeters
Time frame: Baseline to day 28 and day 56
Change of systolic blood pressure and diastolic blood pressure
Time frame: Baseline to day 28 and day 56
Glucose and insulin will be combined to report HOMA-IR in (mg/dl x mIU/L)/405
Time frame: Baseline to day 28 and day 56
Change of high density lipoprotein in the blood
Time frame: Baseline to day 28 and day 56
Change of low density lipoprotein in the blood
Time frame: Baseline to day 28 and day 56
Change of Cholesterol in the blood
Time frame: Baseline to day 28 and day 56
Change of Triglyceride in the blood
Taichung Veterans General Hospital
Other
The Effects of Fermented Milk Product With Probiotic on Helicobacter Pylori Infection, Gut Microbiome and Metabolism.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03434860
Glucose Metabolism Disorders, Hyperinsulinism
View Trial DetailsNCT07619560
Basal Ganglia Diseases, Brain Diseases
Taipei, Taiwan
View Trial DetailsNCT07476573
Athlete, Gut Microbiota
Semarang, Central Java, Indonesia
View Trial DetailsNCT07364383
Microbiome, Probiotic
Sofia, Bulgaria
View Trial Details